Clinical Trials in Philadelphia

Showing 9421-9440 of 20,904 trials

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

NCT04592484

This is a first-in-human, Phase 1/2 open-label, multicenter, dose escalation, safety, pharmacodynamic, and PK study of CDK-002 in subjects with advanced/metastatic, recurrent, injectable solid tumors, whose disease has progressed despite receiving standard of care treatment. CDK 002 will be administered intratumorally (IT). Part A will enroll subjects with advanced/metastatic, recurrent, injectable solid tumors with emphasis on head and neck squamous cell cancer (HNSCC), triple negative breast cancer (TNBC), anaplastic thyroid carcinoma (ATC) and cutaneous squamous cell carcinoma (cSCC).

Advanced Solid Tumor

Codiak BioSciences27 participantsStarted Sep 2020

Scottsdale, Arizona, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +5 more locations

COMPLETEDPhase 3< 1 mile

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

NCT01673867

The purpose of the study is to compare the overall survival of BMS-936558 (Nivolumab) as compared with Docetaxel in subjects with non-squamous cell non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy

Non-Squamous Cell Non-small Cell Lung Cancer

Bristol-Myers Squibb582 participantsStarted Nov 2012

Scottsdale, Arizona, United States • Duarte, California, United States • San Diego, California, United States +116 more locations

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Find Trials by Condition in Philadelphia

eMove - Dance/Movement Therapy Study

Priming With tDCS: Expanding the Window of Recovery in Chronic Stroke

Added Sugar Intake, Sweet Taste Phenotypes and Biomarkers

ECG Belt for CRT Response

Strados System at Center of Excellence

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Sargramostim Use in COVID-19 to Recover Patient Health

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis